Financial Information for Guarantor Subsidiaries and Non-Guarantor Subsidiaries - Supplemental Condensed Consolidating Statement of Cash Flows (Details) - USD ($) $ in Millions | 3 Months Ended |
Mar. 31, 2018 | Mar. 31, 2017 |
Condensed Financial Statements | | |
Net cash (used in) provided by operating activities | $ 29.9 | $ 111 |
Cash flows from investing activities: | | |
Capital expenditures | (88) | (61.3) |
Acquisitions of businesses, net of cash acquired | (274.1) | (21.5) |
Distributions of capital from equity investments | 1.5 | 1.3 |
Changes in other assets and liabilities and other | 0 | 2 |
Other, principally change in intercompany investing activities | 0 | 0 |
Net cash used in investing activities | (360.6) | (79.5) |
Cash flows from financing activities: | | |
Net payments of long-term debt including proceeds and repurchases of senior notes and term loans | 5.3 | 22.5 |
Repayment of assumed NYX debt | (288.2) | 0 |
Payments of debt issuance and deferred financing costs | (38.5) | (27.2) |
Payments on license obligations | (6.5) | (9.8) |
Net redemptions of common stock under stock-based compensation plans and other | (17.7) | (0.6) |
Other, principally change in intercompany financing activities | 0 | 0 |
Net cash provided by (used in) financing activities | (345.6) | (15.1) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 1.9 | 2.5 |
Increase (decrease) in cash, cash equivalents and restricted cash | (674.4) | 18.9 |
Cash, cash equivalents and restricted cash, beginning of period | 834.1 | 156.9 |
Cash, cash equivalents and restricted cash, end of period | 159.7 | 175.8 |
Reportable Legal Entities | SGI (Issuer) | | |
Condensed Financial Statements | | |
Net cash (used in) provided by operating activities | (25.4) | (20.9) |
Cash flows from investing activities: | | |
Capital expenditures | (17.1) | (4.7) |
Acquisitions of businesses, net of cash acquired | 0 | 0 |
Distributions of capital from equity investments | 0 | 0 |
Changes in other assets and liabilities and other | | 0 |
Other, principally change in intercompany investing activities | 74 | (221.9) |
Net cash used in investing activities | 56.9 | (226.6) |
Cash flows from financing activities: | | |
Net payments of long-term debt including proceeds and repurchases of senior notes and term loans | 7.1 | 274 |
Repayment of assumed NYX debt | 0 | |
Payments of debt issuance and deferred financing costs | (38.5) | (27.2) |
Payments on license obligations | 0 | 0 |
Net redemptions of common stock under stock-based compensation plans and other | 0 | 0 |
Other, principally change in intercompany financing activities | 0 | 0 |
Net cash provided by (used in) financing activities | (31.4) | 246.8 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 0 | 0 |
Increase (decrease) in cash, cash equivalents and restricted cash | 0.1 | (0.7) |
Cash, cash equivalents and restricted cash, beginning of period | 0.6 | 1.7 |
Cash, cash equivalents and restricted cash, end of period | 0.7 | 1 |
Reportable Legal Entities | SGC (Parent) | | |
Condensed Financial Statements | | |
Net cash (used in) provided by operating activities | (32) | (62.2) |
Cash flows from investing activities: | | |
Capital expenditures | (7.9) | (9.3) |
Acquisitions of businesses, net of cash acquired | 0 | 0 |
Distributions of capital from equity investments | 0 | 0 |
Changes in other assets and liabilities and other | | 0 |
Other, principally change in intercompany investing activities | 0 | 0 |
Net cash used in investing activities | (7.9) | (9.3) |
Cash flows from financing activities: | | |
Net payments of long-term debt including proceeds and repurchases of senior notes and term loans | 0 | (250) |
Repayment of assumed NYX debt | 0 | |
Payments of debt issuance and deferred financing costs | 0 | 0 |
Payments on license obligations | (6.5) | (9.2) |
Net redemptions of common stock under stock-based compensation plans and other | (15.9) | (0.6) |
Other, principally change in intercompany financing activities | (629.6) | 336.4 |
Net cash provided by (used in) financing activities | (652) | 76.6 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 0 | 0 |
Increase (decrease) in cash, cash equivalents and restricted cash | (691.9) | 5.1 |
Cash, cash equivalents and restricted cash, beginning of period | 732.6 | 32.7 |
Cash, cash equivalents and restricted cash, end of period | 40.7 | 37.8 |
Reportable Legal Entities | Guarantor Subsidiaries | | |
Condensed Financial Statements | | |
Net cash (used in) provided by operating activities | 34.3 | 104.3 |
Cash flows from investing activities: | | |
Capital expenditures | (44.5) | (26.2) |
Acquisitions of businesses, net of cash acquired | (9.6) | (21.5) |
Distributions of capital from equity investments | 0 | 0 |
Changes in other assets and liabilities and other | | 0 |
Other, principally change in intercompany investing activities | 0 | 0 |
Net cash used in investing activities | (54.1) | (47.7) |
Cash flows from financing activities: | | |
Net payments of long-term debt including proceeds and repurchases of senior notes and term loans | 0 | 0 |
Repayment of assumed NYX debt | 0 | |
Payments of debt issuance and deferred financing costs | 0 | 0 |
Payments on license obligations | 0 | (0.6) |
Net redemptions of common stock under stock-based compensation plans and other | (1.8) | 0 |
Other, principally change in intercompany financing activities | 21.9 | (53.9) |
Net cash provided by (used in) financing activities | 20.1 | (54.5) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 0 | 0 |
Increase (decrease) in cash, cash equivalents and restricted cash | 0.3 | 2.1 |
Cash, cash equivalents and restricted cash, beginning of period | 43.9 | 41 |
Cash, cash equivalents and restricted cash, end of period | 44.2 | 43.1 |
Reportable Legal Entities | Non-Guarantor Subsidiaries | | |
Condensed Financial Statements | | |
Net cash (used in) provided by operating activities | 55.4 | 94.3 |
Cash flows from investing activities: | | |
Capital expenditures | (18.5) | (21.1) |
Acquisitions of businesses, net of cash acquired | (264.5) | 0 |
Distributions of capital from equity investments | 1.5 | 1.3 |
Changes in other assets and liabilities and other | | 2 |
Other, principally change in intercompany investing activities | 0 | (60.6) |
Net cash used in investing activities | (281.5) | (78.4) |
Cash flows from financing activities: | | |
Net payments of long-term debt including proceeds and repurchases of senior notes and term loans | (1.8) | (1.5) |
Repayment of assumed NYX debt | (288.2) | |
Payments of debt issuance and deferred financing costs | 0 | 0 |
Payments on license obligations | 0 | 0 |
Net redemptions of common stock under stock-based compensation plans and other | 0 | 0 |
Other, principally change in intercompany financing activities | 533.7 | 0 |
Net cash provided by (used in) financing activities | 243.7 | (1.5) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 1.9 | 2.5 |
Increase (decrease) in cash, cash equivalents and restricted cash | 19.5 | 16.9 |
Cash, cash equivalents and restricted cash, beginning of period | 60.2 | 82.6 |
Cash, cash equivalents and restricted cash, end of period | 79.7 | 99.5 |
Eliminating Entries | | |
Condensed Financial Statements | | |
Net cash (used in) provided by operating activities | (2.4) | (4.5) |
Cash flows from investing activities: | | |
Capital expenditures | 0 | 0 |
Acquisitions of businesses, net of cash acquired | 0 | 0 |
Distributions of capital from equity investments | 0 | 0 |
Changes in other assets and liabilities and other | | 0 |
Other, principally change in intercompany investing activities | (74) | 282.5 |
Net cash used in investing activities | (74) | 282.5 |
Cash flows from financing activities: | | |
Net payments of long-term debt including proceeds and repurchases of senior notes and term loans | 0 | 0 |
Repayment of assumed NYX debt | 0 | |
Payments of debt issuance and deferred financing costs | 0 | 0 |
Payments on license obligations | 0 | 0 |
Net redemptions of common stock under stock-based compensation plans and other | 0 | 0 |
Other, principally change in intercompany financing activities | 74 | (282.5) |
Net cash provided by (used in) financing activities | 74 | (282.5) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | 0 | 0 |
Increase (decrease) in cash, cash equivalents and restricted cash | (2.4) | (4.5) |
Cash, cash equivalents and restricted cash, beginning of period | (3.2) | (1.1) |
Cash, cash equivalents and restricted cash, end of period | $ (5.6) | $ (5.6) |